In diesem Abschnitt werden die Veröffentlichungen zur Forschung im Rahmen von NCER-PD aufgeführt, wie beispielweise Ergebnisse aus der Luxemburger Parkinson-Studie. Sie können die folgende Liste nach Jahr sortiert durchsuchen. Für einige Veröffentlichungen haben wir bereits eine Zusammenfassung in Englisch, Deutsch und Französisch zur Verfügung gestellt.
2022
Domenighetti, C., Sugier, P., Ashok Kumar Sreelatha, A., Schulte, C., Grover, S., Mohamed, O., Portugal, B., May, P., Bobbili, D. R., Radivojkov‐Blagojevic, M., Lichtner, P., Singleton, A. B., Hernandez, D. G., Edsall, C., Mellick, G. D., Zimprich, A., Pirker, W., Rogaeva, E., Lang, A. E., … the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (Courage‐PD) Consortium. (2022). Dairy Intake and Parkinson’s Disease: A Mendelian Randomization Study. Movement Disorders, mds.28902. https://doi.org/10.1002/mds.28902
Koko, M., Motelow, J. E., Stanley, K. E., Bobbili, D. R., Dhindsa, R. S., May, P., Canadian Epilepsy Network, Epi4K Consortium, Epilepsy Phenome/Genome Project, EpiPGX Consortium, EuroEPINOMICS‐CoGIE Consortium, Alldredge, B. K., Allen, A. S., Altmüller, J., Amrom, D., Andermann, E., Auce, P., Avbersek, A., Baulac, S., … Zimprich, F. (2022). Association of ultra‐rare coding variants with genetic generalized epilepsy: A case–control whole exome sequencing study. Epilepsia, epi.17166. https://doi.org/10.1111/epi.17166
on behalf of the Comprehensive Unbiaised Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (Courage-PD) consortium, Domenighetti, C., Sugier, P.-E., Sreelatha, A. A. K., Schulte, C., Grover, S., Mohamed, O., Portugal, B., May, P., Bobbili, D. R., Radivojkov-Blagojevic, M., Lichtner, P., Singleton, A. B., Hernandez, D. G., Edsall, C., Mellick, G. D., Zimprich, A., Pirker, W., Rogaeva, E., … Elbaz, A. (2022). Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease. Journal of Parkinson’s Disease, 12(1), 267–282. https://doi.org/10.3233/JPD-212851
on behalf of the NCER-PD Consortium, Hanff, A.-M., Leist, A. K., Fritz, J. V., Pauly, C., Krüger, R., & Halek, M. (2022). Determinants of Self-Stigma in People with Parkinson’s Disease: A Mixed Methods Scoping Review. Journal of Parkinson’s Disease, 12(2), 509–522. https://doi.org/10.3233/JPD-212869
Schmitz, S., Vaillant, M., Renoux, C., Konsbruck, R. L., Hertz, P., Perquin, M., Pavelka, L., Krüger, R., & Huiart, L. (2022). Prevalence and Cost of Care for Parkinson’s Disease in Luxembourg: An Analysis of National Healthcare Insurance Data. PharmacoEconomics - Open. https://doi.org/10.1007/s41669-021-00321-3
Vega, C., Gawron, P., Lebioda, J., Grouès, V., Matyjaszczyk, P., Pauly, C., Smula, E., Krüger, R., Schneider, R., & Satagopam, V. (2022). Smart Scheduling (SMASCH): multi-appointment scheduling system for longitudinal clinical research studies. JAMIA Open, 5(2), ooac038. https://doi.org/10.1093/jamiaopen/ooac038
Zagare, A., Barmpa, K., Smajic, S., Smits, L. M., Grzyb, K., Grünewald, A., Skupin, A., Nickels, S. L., & Schwamborn, J. C. (2022). Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression. The American Journal of Human Genetics, 109(2), 311–327. https://doi.org/10.1016/j.ajhg.2021.12.009
2021
Barbuti, P. A., Ohnmacht, J., Santos, B. F. R., Antony, P. M., Massart, F., Cruciani, G., Dording, C. M., Pavelka, L., Casadei, N., Kwon, Y.-J., & Krüger, R. (2021). Gene-corrected p.A30P SNCA patient-derived isogenic neurons rescue neuronal branching and function. Scientific Reports, 11(1), 21946. https://doi.org/10.1038/s41598-021-01505-x
Becker, S., Pauly, C., Lawton, M., Hipp, G., Bowring, F., Sulzer, P., Hu, M., Krüger, R., Gasser, T., & Liepelt-Scarfone, I. (2021). Quantifying activities of daily living impairment in Parkinson’s disease using the Functional Activities Questionnaire. Neurological Sciences. https://doi.org/10.1007/s10072-021-05365-1
Brown, S. J., Boussaad, I., Jarazo, J., Fitzgerald, J. C., Antony, P., Keatinge, M., Blechman, J., Schwamborn, J. C., Krüger, R., Placzek, M., & Bandmann, O. (2021). PINK1 deficiency impairs adult neurogenesis of dopaminergic neurons. Scientific Reports, 11(1), 6617. https://doi.org/10.1038/s41598-021-84278-7
Chia, Ruth, R., Sabir, M. S., Bandres-Ciga, S., Saez-Atienzar, S., Reynolds, R. H., Gustavsson, E., Walton, R. L., Ahmed, S., Viollet, C., Ding, J., Makarious, M. B., Diez-Fairen, M., Portley, M. K., Shah, Z., Abramzon, Y., Hernandez, D. G., Blauwendraat, C., Stone, D. J., Eicher, J., … Scholz, S. W. (2021). Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nature Genetics, 53(3), 294–303. https://doi.org/10.1038/s41588-021-00785-3
Giovagnoni, C., Ali, M., Eijssen, L. M. T., Maes, R., Choe, K., Mulder, M., Kleinjans, J., del Sol, A., Glaab, E., Mastroeni, D., Delvaux, E., Coleman, P., Losen, M., Pishva, E., Martinez-Martinez, P., & van den Hove, D. L. A. (2021). Altered sphingolipid function in Alzheimer’s disease; a gene regulatory network approach. Neurobiology of Aging, 102, 178–187. https://doi.org/10.1016/j.neurobiolaging.2021.02.001
Glaab, E., Rauschenberger, A., Banzi, R., Gerardi, C., Garcia, P., & Demotes, J. (2021). Biomarker discovery studies for patient stratification using machine learning analysis of omics data: a scoping review. BMJ Open, 11(12), e053674. https://doi.org/10.1136/bmjopen-2021-053674
Grover, S., Kumar‐Sreelatha, A. A., Bobbili, D. R., May, P., Domenighetti, C., Sugier, P., Schulte, C., COURAGE‐PD Consortium, Elbaz, A., Krüger, R., Gasser, T., Sharma, M., & COURAGE‐PD Consortium. (2021). Replication of a Novel Parkinson’s Locus in a European Ancestry Population. Movement Disorders, 36(7), 1689–1695. https://doi.org/10.1002/mds.28546
Hanff, A.-M., Pauly, C., Pauly, L., Schröder, V. E., Hansen, M., Meyers, G. R., Kaysen, A., Hansen, L., Wauters, F., & Krüger, R. (2021). Unmet Needs of People With Parkinson’s Disease and Their Caregivers During COVID-19-Related Confinement: An Explorative Secondary Data Analysis. Frontiers in Neurology, 11, 615172. https://doi.org/10.3389/fneur.2020.615172
Hassanin, E., May, P., Aldisi, R., Spier, I., Forstner, A. J., Nöthen, M. M., Aretz, S., Krawitz, P., Bobbili, D. R., & Maj, C. (2021a). Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history. Genetics in Medicine, S1098360021053879. https://doi.org/10.1016/j.gim.2021.11.009
Imm, J., Pishva, E., Ali, M., Kerrigan, T. L., Jeffries, A., Burrage, J., Glaab, E., Cope, E. L., Jones, K. M., Allen, N. D., & Lunnon, K. (2021). Characterization of DNA Methylomic Signatures in Induced Pluripotent Stem Cells During Neuronal Differentiation. Frontiers in Cell and Developmental Biology, 9, 647981. https://doi.org/10.3389/fcell.2021.647981
Kaczmarek, A. T., Bahlmann, N., Thaqi, B., May, P., & Schwarz, G. (2021). Machine learning-based identification and characterization of 15 novel pathogenic SUOX missense mutations. Molecular Genetics and Metabolism, 134(1–2), 188–194. https://doi.org/10.1016/j.ymgme.2021.07.011
Kaivola, K., Shah, Z., Chia, R., International LBD Genomics Consortium, & Scholz, S. W. (2021). Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. Brain, awab402. https://doi.org/10.1093/brain/awab402
Hassanin, E., May, P., Aldisi, R., Krawitz, P., Maj, C., & Bobbili, D. R. (2021). Assessing the role of polygenic background on the penetrance of monogenic forms in Parkinson’s disease [Preprint]. Genetic and Genomic Medicine. https://doi.org/10.1101/2021.06.06.21253270
Kern, F., Fehlmann, T., Violich, I., Alsop, E., Hutchins, E., Kahraman, M., Grammes, N. L., Guimarães, P., Backes, C., Poston, K. L., Casey, B., Balling, R., Geffers, L., Krüger, R., Galasko, D., Mollenhauer, B., Meese, E., Wyss-Coray, T., Craig, D. W., … Keller, A. (2021). Deep sequencing of sncRNAs reveals hallmarks and regulatory modules of the transcriptome during Parkinson’s disease progression. Nature Aging, 1(3), 309–322. https://doi.org/10.1038/s43587-021-00042-6
Koko, M., Krause, R., Sander, T., Bobbili, D. R., Nothnagel, M., May, P., Lerche, H., Feng, Y.-C. A., Howrigan, D. P., Abbott, L. E., Tashman, K., Cerrato, F., Singh, T., Heyne, H., Byrnes, A., Churchhouse, C., Watts, N., Solomonson, M., Lal, D., … Neale, B. M. (2021). Distinct gene-set burden patterns underlie common generalized and focal epilepsies. EBioMedicine, 72, 103588. https://doi.org/10.1016/j.ebiom.2021.103588
Mencke, P., Boussaad, I., Romano, C. D., Kitami, T., Linster, C. L., & Krüger, R. (2021). The Role of DJ-1 in Cellular Metabolism and Pathophysiological Implications for Parkinson’s Disease. Cells, 10(2), 347. https://doi.org/10.3390/cells10020347
Rauschenberger, A., & Glaab, E. (2021). Predicting correlated outcomes from molecular data. Bioinformatics, 37(21), 3889–3895. https://doi.org/10.1093/bioinformatics/btab576
Rauschenberger, A., Glaab, E., & van de Wiel, M. A. (2021). Predictive and interpretable models via the stacked elastic net. Bioinformatics, 37(14), 2012–2016. https://doi.org/10.1093/bioinformatics/btaa535
Smajić, S., Prada-Medina, C. A., Landoulsi, Z., Ghelfi, J., Delcambre, S., Dietrich, C., Jarazo, J., Henck, J., Balachandran, S., Pachchek, S., Morris, C. M., Antony, P., Timmermann, B., Sauer, S., Pereira, S. L., Schwamborn, J. C., May, P., Grünewald, A., & Spielmann, M. (2021). Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain, awab446. https://doi.org/10.1093/brain/awab446
The Global Parkinson’s Genetics Program. (2021). GP2: The Global Parkinson’s Genetics Program. Movement Disorders, 36(4), 842–851. https://doi.org/10.1002/mds.28494
the Parkinson’s Disease Digital Biomarker Challenge Consortium, Sieberts, S. K., Schaff, J., Duda, M., Pataki, B. Á., Sun, M., Snyder, P., Daneault, J.-F., Parisi, F., Costante, G., Rubin, U., Banda, P., Chae, Y., Chaibub Neto, E., Dorsey, E. R., Aydın, Z., Chen, A., Elo, L. L., Espino, C., … Omberg, L. (2021). Crowdsourcing digital health measures to predict Parkinson’s disease severity: the Parkinson’s Disease Digital Biomarker DREAM Challenge. Npj Digital Medicine, 4(1), 53. https://doi.org/10.1038/s41746-021-00414-7
van Rumund, A., Pavelka, L., Esselink, R. A. J., Geurtz, B. P. M., Wevers, R. A., Mollenhauer, B., Krüger, R., Bloem, B. R., & Verbeek, M. M. (2021). Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase. Npj Parkinson’s Disease, 7(1), 29. https://doi.org/10.1038/s41531-021-00172-z
2020
Antony, P.M.A., Kondratyeva, O., Mommaerts, K. et al. (2020) Fibroblast mitochondria in idiopathic Parkinson’s disease display morphological changes and enhanced resistance to depolarization. Sci Rep, 10, 1569. https://doi.org/10.1038/s41598-020-58505-6
Baldini, F., Hertel, J., Sandt, E., Thinnes, C. C., Neuberger-Castillo, L., Pavelka, L., Betsou, F., Krüger, R., & Thiele, I. (2020). Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biology, 18(1), 62. https://doi.org/10.1186/s12915-020-00775-7 >> Lesen Sie die Zusammenfassung
Barbe, M. T., Tonder, L., Krack, P., Debû, B., Schüpbach, M., Paschen, S., Dembek, T. A., Kühn, A. A., Fraix, V., Brefel-Courbon, C., Wojtecki, L., Maltête, D., Damier, P., Sixel-Döring, F., Weiss, D., Pinsker, M., Witjas, T., Thobois, S., Schade-Brittinger, C., Rau, J., … EARLYSTIM study group (2020). Deep Brain Stimulation for Freezing of Gait in Parkinson's Disease With Early Motor Complications. Movement disorders : official journal of the Movement Disorder Society, 35(1), pp 82–90. https://doi.org/10.1002/mds.27892
Berenguer-Escuder, C., Grossmann, D., Antony, P., Arena, G., Wasner, K., Massart, F., Jarazo, J., Walter, J., Schwamborn, J. C., Grünewald, A., & Krüger, R. (2020). Impaired mitochondrial-endoplasmic reticulum interaction and mitophagy in Miro1-mutant neurons in Parkinson's disease. Human molecular genetics, 29(8), 1353–1364. https://doi.org/10.1093/hmg/ddaa066
Bobbili, D.R., Banda, P., Krüger, R., May, P. (2020) Excess of singleton loss-of-function variants in Parkinson's disease contributes to genetic risk. Journal of Medical Genetics, 57(9), pp 617-623. https://doi.org/10.1136/jmedgenet-2019-106316.
Boussaad, I., Obermaier, C. D., Hanss, Z., Bobbili, D. R., Bolognin, S., Glaab, E., Wołyńska, K., Weisschuh, N., De Conti, L., May, C., Giesert, F., Grossmann, D., Lambert, A., Kirchen, S., Biryukov, M., Burbulla, L. F., Massart, F., Bohler, J., Cruciani, G., Schmid, B., … Krüger, R. (2020). A patient-based model of RNA mis-splicing uncovers treatment targets in Parkinson's disease. Science translational medicine, 12(560), eaau3960. https://doi.org/10.1126/scitranslmed.aau3960 >> Lesen Sie die Zusammenfassung
EuroEPINOMICS-RES Consortium, Lal, D., May, P., Perez-Palma, E., Samocha, K. E., Kosmicki, J. A., Robinson, E. B., Møller, R. S., Krause, R., Nürnberg, P., Weckhuysen, S., De Jonghe, P., Guerrini, R., Niestroj, L. M., Du, J., Marini, C., Ware, J. S., Kurki, M., Gormley, P., … Daly, M. J. (2020). Gene family information facilitates variant interpretation and identification of disease-associated genes in neurodevelopmental disorders. Genome Medicine, 12(1), 28. https://doi.org/10.1186/s13073-020-00725-6Fehlmann, T., Kahraman, M., Ludwig, N., Backes, C., Galata, V., Keller, V., Geffers, L., Mercaldo, N., Hornung, D., Weis, T., Kayvanpour, E., Abu-Halima, M., Deuschle, C., Schulte, C., Suenkel, U., von Thaler, A.-K., Maetzler, W., Herr, C., Fähndrich, S., … Keller, A. (2020). Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients. JAMA Oncology, 6(5), 714. https://doi.org/10.1001/jamaoncol.2020.0001
Hanss, Z., Boussaad, I., Jarazo, J., Schwamborn, J. C., & Krüger, R. (2020). Quality Control Strategy for CRISPR-Cas9-Based Gene Editing Complicated by a Pseudogene. Frontiers in genetics, 10, 1297. https://doi.org/10.3389/fgene.2019.01297
Hendrickx, D. M., & Glaab, E. (2020). Comparative transcriptome analysis of Parkinson’s disease and Hutchinson-Gilford progeria syndrome reveals shared susceptible cellular network processes. BMC Medical Genomics, 13(1), 114. https://doi.org/10.1186/s12920-020-00761-6
Heyne, H. O., Baez-Nieto, D., Iqbal, S., Palmer, D. S., Brunklaus, A., May, P., Epi25 Collaborative, Johannesen, K. M., Lauxmann, S., Lemke, J. R., Møller, R. S., Pérez-Palma, E., Scholl, U. I., Syrbe, S., Lerche, H., Lal, D., Campbell, A. J., Wang, H.-R., Pan, J., & Daly, M. J. (2020). Predicting functional effects of missense variants in voltage-gated sodium and calcium channels. Science Translational Medicine, 12(556), eaay6848. https://doi.org/10.1126/scitranslmed.aay6848Iqbal, S., Hoksza, D., Pérez-Palma, E., May, P., Jespersen, J. B., Ahmed, S. S., Rifat, Z. T., Heyne, H. O., Rahman, M. S., Cottrell, J. R., Wagner, F. F., Daly, M. J., Campbell, A. J., & Lal, D. (2020). MISCAST: MIssense variant to protein StruCture Analysis web SuiTe. Nucleic Acids Research, 48(W1), W132–W139. https://doi.org/10.1093/nar/gkaa361
Iqbal, S., Pérez-Palma, E., Jespersen, J. B., May, P., Hoksza, D., Heyne, H. O., Ahmed, S. S., Rifat, Z. T., Rahman, M. S., Lage, K., Palotie, A., Cottrell, J. R., Wagner, F. F., Daly, M. J., Campbell, A. J., & Lal, D. (2020). Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variants. Proceedings of the National Academy of Sciences, 117(45), 28201–28211. https://doi.org/10.1073/pnas.2002660117
Kern, F., Fehlmann, T., Violich, I., Alsop, E., Hutchins, E., Kahraman, M., Grammes, N. L., Guimarães, P., Backes, C., Poston, K., Casey, B., Balling, R., Geffers, L., Krüger, R., Galasko, D., Mollenhauer, B., Meese, E., Wyss-Coray, T., Craig, D. W., … Keller, A. (2020). Deep sncRNA-seq of the PPMI cohort to study Parkinson’s disease progression [Preprint]. Neuroscience. https://doi.org/10.1101/2020.06.01.127092
Larsen, S.B., Hanss, Z., Cruciani, G., Massart, F., Barbuti, P.A., Mellick, G., Krüger, R. (2020) Induced pluripotent stem cell line (LCSBi001-A) derived from a patient with Parkinson's disease carrying the p.D620N mutation in VPS35. Stem Cell Res, 45, 101776. https://doi.org/10.1016/j.scr.2020.101776.
Monzel, A. S., Hemmer, K., Kaoma, T., Smits, L. M., Bolognin, S., Lucarelli, P., Rosety, I., Zagare, A., Antony, P., Nickels, S. L., Krueger, R., Azuaje, F., & Schwamborn, J. C. (2020). Machine learning-assisted neurotoxicity prediction in human midbrain organoids. Parkinsonism & related disorders, 75, 105–109. https://doi.org/10.1016/j.parkreldis.2020.05.011
Ohnmacht, J., May, P., Sinkkonen, L., & Krüger, R. (2020). Missing heritability in Parkinson's disease: the emerging role of non-coding genetic variation. Journal of neural transmission (Vienna, Austria : 1996), 127(5), 729–748. https://doi.org/10.1007/s00702-020-02184-0
Rajan, R., Divya, K. P., Kandadai, R. M., Yadav, R., Satagopam, V. P., Madhusoodanan, U. K., Agarwal, P., Kumar, N., Ferreira, T., Kumar, H., Sreeram Prasad, A. V., Shetty, K., Mehta, S., Desai, S., Kumar, S., Prashanth, L. K., Bhatt, M., Wadia, P., Ramalingam, S., … The Lux-GIANT Consortium. (2020). Genetic Architecture of Parkinson’s Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson’s Disease Research. Frontiers in Neurology, 11, 524. https://doi.org/10.3389/fneur.2020.00524Schote, A. B., Schiel, F., Schmitt, B., Winnikes, U., Frank, N., Gross, K., Croyé, M.-A., Tarragon, E., Bekhit, A., Bobbili, D. R., May, P., Schick, C., & Meyer, J. (2020). Genome-wide linkage analysis of families with primary hyperhidrosis. PLOS ONE, 15(12), e0244565. https://doi.org/10.1371/journal.pone.0244565
Stute, L., & Krüger, R. (2020). [Emerging concepts for precision medicine in Parkinson's disease with focus on genetics]. Fortschritte Der Neurologie-Psychiatrie. https://doi.org/10.1055/a-1149-2204.
Vega, C., Grouès, V., Ostaszewski, M., Schneider, R., & Satagopam, V. (2020). BioKC: a collaborative platform for systems biology model curation and annotation [Preprint]. Systems Biology. https://doi.org/10.1101/2020.10.01.322438Woitalla D, Krüger R, Lorenzl S, et al. (2020) [The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease]. Fortschritte der Neurologie-psychiatrie. https://doi.org/10.1055/a-1149-9308
2019
Bolognin, S., Fossépré, M., Qing, X., Jarazo, J., Ščančar, J., Moreno, E. L., Nickels, S. L., Wasner, K., Ouzren, N., Walter, J., Grünewald, A., Glaab, E., Salamanca, L., Fleming, R., Antony, P., & Schwamborn, J. C. (2018). 3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 6(1), 1800927. https://doi.org/10.1002/advs.201800927
Glaab, E., Trezzi, J. P., Greuel, A., Jäger, C., Hodak, Z., Drzezga, A., Timmermann, L., Tittgemeyer, M., Diederich, N. J., & Eggers, C. (2019). Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson's disease. Neurobiology of disease, 124, 555–562. https://doi.org/10.1016/j.nbd.2019.01.003
Hertel, J., Harms, A. C., Heinken, A., Baldini, F., Thinnes, C. C., Glaab, E., Vasco, D. A., Pietzner, M., Stewart, I. D., Wareham, N. J., Langenberg, C., Trenkwalder, C., Krüger, R., Hankemeier, T., Fleming, R., Mollenhauer, B., & Thiele, I. (2019). Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson's Disease. Cell reports, 29(7), 1767–1777.e8. https://doi.org/10.1016/j.celrep.2019.10.035
Kishore, A., Ashok Kumar Sreelatha, A., Sturm, M., von-Zweydorf, F., Pihlstrøm, L., Raimondi, F., Russell, R., Lichtner, P., Banerjee, M., Krishnan, S., Rajan, R., Puthenveedu, D. K., Chung, S. J., International Parkinson's Disease Genomics Consortium (IPDGC), Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD), Bauer, P., Riess, O., Gloeckner, C. J., Kruger, R., Gasser, T., … Sharma, M. (2019). Understanding the role of genetic variability in LRRK2 in Indian population. Movement disorders : official journal of the Movement Disorder Society, 34(4), 496–505. https://doi.org/10.1002/mds.27558
Nickels, S.L., Walter, J., Bolognin, S., et al. (2019) Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients. Parkinsonism Relat. Disord., 67, pp.48–55.
Riederer, P., Berg, D., Casadei, N., Cheng, F., Classen, J., Dresel, C., Jost, W., Krüger, R., Müller, T., Reichmann, H., Rieß, O., Storch, A., Strobel, S., van Eimeren, T., Völker, H. U., Winkler, J., Winklhofer, K. F., Wüllner, U., Zunke, F., & Monoranu, C. M. (2019). α-Synuclein in Parkinson's disease: causal or bystander?. Journal of neural transmission (Vienna, Austria : 1996), 126(7), 815–840. https://doi.org/10.1007/s00702-019-02025-9
Schuepbach, W., Tonder, L., Schnitzler, A., Krack, P., Rau, J., Hartmann, A., Hälbig, T. D., Pineau, F., Falk, A., Paschen, L., Paschen, S., Volkmann, J., Dafsari, H. S., Barbe, M. T., Fink, G. R., Kühn, A., Kupsch, A., Schneider, G. H., Seigneuret, E., Fraix, V., … EARLYSTIM study group (2019). Quality of life predicts outcome of deep brain stimulation in early Parkinson disease. Neurology, 92(10), e1109–e1120. https://doi.org/10.1212/WNL.0000000000007037
Simons, J. A., Vaillant, M., Hipp, G., Pavelka, L., Stute, L., Pauly, C., & Krüger, R. (2019). Multilingual Validation of the First French Version of Munich Dysphagia Test-Parkinson's Disease (MDT-PD) in the Luxembourg Parkinson's Study. Frontiers in neurology, 10, 1180. https://doi.org/10.3389/fneur.2019.01180
Vollstedt, E. J., Kasten, M., Klein, C., & MJFF Global Genetic Parkinson's Disease Study Group (2019). Using global team science to identify genetic parkinson's disease worldwide. Annals of neurology, 86(2), 153–157. https://doi.org/10.1002/ana.25514
2018
Blauwendraat, C., Reed, X., Kia, D. A., Gan-Or, Z., Lesage, S., Pihlstrøm, L., Guerreiro, R., Gibbs, J. R., Sabir, M., Ahmed, S., Ding, J., Alcalay, R. N., Hassin-Baer, S., Pittman, A. M., Brooks, J., Edsall, C., Hernandez, D. G., Chung, S. J., Goldwurm, S., Toft, M., … COURAGE-PD (Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease) Consortium, the French Parkinson’s Disease Consortium, and the International Parkinson’s Disease Genomics Consortium (IPDGC) (2018). Frequency of Loss of Function Variants in LRRK2 in Parkinson Disease. JAMA neurology, 75(11), 1416–1422. https://doi.org/10.1001/jamaneurol.2018.1885
Fitzgerald, J.C., Zimprich, A., Reddy Bobbili, D., Sharma, M., May, P., Krüger, R. (2018) Reply: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease. Brain, 141(3), p. e17, https://doi.org/10.1093/brain/awx380
Hipp, G., Vaillant, M., Diederich, N. J., Roomp, K., Satagopam, V. P., Banda, P., Sandt, E., Mommaerts, K., Schmitz, S. K., Longhino, L., Schweicher, A., Hanff, A. M., Nicolai, B., Kolber, P., Reiter, D., Pavelka, L., Binck, S., Pauly, C., Geffers, L., Betsou, F., … Krüger, R. (2018). The Luxembourg Parkinson's Study: A Comprehensive Approach for Stratification and Early Diagnosis. Frontiers in aging neuroscience, 10, p 326. https://doi.org/10.3389/fnagi.2018.00326
Klucken, J., Krüger, R., Schmidt, P., & Bloem, B. R. (2018). Management of Parkinson's Disease 20 Years from Now: Towards Digital Health Pathways. Journal of Parkinson's disease, 8(s1), S85–S94. https://doi.org/10.3233/JPD-181519
Larsen, S. B., Hanss, Z., & Krüger, R. (2018). The genetic architecture of mitochondrial dysfunction in Parkinson's disease. Cell and tissue research, 373(1), 21–37. https://doi.org/10.1007/s00441-017-2768-8
Lhommee, E., Wojtecki, L., Czernecki, V., Witt, K., Maier, F., Tonder, L., Timmermann, L., Halbig, T. D., Pineau, F., Durif, F., Witjas, T., Pinsker, M., Mehdorn, M., Sixel-Doring, F., Kupsch, A., Krüger, R., Elben, S., Chabardes, S., Thobois, S., Brefel-Courbon, C., Ory-Magne, F., Regis, J.-M., Maltete, D., Sauvaget, A., Rau, J., Schnitzler, A., Schupbach, M., Schade-Brittinger, C., Deuschl, G., Houeto, J.-L., & Krack, P. (2018). Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial. Lancet Neurol., 17(3), pp. 223-231. doi: 10.1016/S1474-4422(18)30035-8.
Riederer, P., Jellinger, K. A., Kolber, P., Hipp, G., Sian-Hülsmann, J., & Krüger, R. (2018). Lateralisation in Parkinson disease. Cell and tissue research, 373(1), 297–312. https://doi.org/10.1007/s00441-018-2832-z
2017
Antonini, A., Poewe, W., Chaudhuri, K. R., Jech, R., Pickut, B., Pirtošek, Z., Szasz, J., Valldeoriola, F., Winkler, C., Bergmann, L., Yegin, A., Onuk, K., Barch, D., Odin, P., Amalia, E., Arnold, G., Bajenaru, O., Bergmans, B., Bjornara, K. A., ... GLORIA study co-investigators (2017). Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry. Parkinsonism and Related Disorders, 45, pp 13-20. https://doi.org/10.1016/j.parkreldis.2017.09.018
Ashrafi, A., Garcia, P., Kollmus, H., Schughart, K., del Sol, A., Buttini, M., Glaab, E. (2017) Absence of regulator of G-protein signaling 4 does not protect against dopamine neuron dysfunction and injury in the mouse 6-hydroxydopamine lesion model of Parkinson's disease, Neurobiology of Aging, 58, pp. 30, doi: 10.1016/j.neurobiolaging.2017.06.008
Blauwendraat, C., Faghri, F., Pihlstrom, L., Geiger, J. T., Elbaz, A., Lesage, S., May, P., Aude, N., Abramzon, Y., Murphy, N. A., Gibbs, J. R., Ryten, M., Ferrari, R., Bras, J., Guerreiro, R., Williams, J., Sims, R., Lubbe, S., Hernandez, D. G., Mok, K. Y., Robak, L., Camphell, R. H., Rogaeva, E., Traynor, B. J., Chia, R., Chung, S. J., International Parkinson’s Disease Genomics Consortium (IPDGC), COURAGE-PD Consortium, Glaab, E., Balling, R., Hardy, J. A., Brice, A., Houlden, H., Shulman, J. M., Morris, H. R., Gasser, T., Heutink, P., Krüger, R., Sharma, M., Simon-Sanchez, J., Nalls, M. A., Singleton, A. B., & Scholz, S. W. (2017) NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases. Neurobiology of Aging, 57, pp 247.e9-247.e13. https://doi.org/10.1016/j.neurobiolaging.2017.05.009
Bobbili, D. R., May, P., & Krüger, R. (2017). Rare variant analysis of the PPMI dataset to uncover the complex genetic architecture of Parkinson’s disease. Movement Disorders : Official Journal of the Movement Disorder Society, 322(Supplement S2), 405.
Burbulla, L. F., Song, P., Mazzulli, J. R., Zampese, E., Wong, Y. C., Jeon, S., Santos, D. P., Blanz, J., Obermaier, C. D., Strojny, C., Savas, J. N., Kiskinis, E., Zhuang, X., Krüger, R., Surmeier, D. J., & Krainc, D. (2017). Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science, 357(6357), 1255-1261. https://doi.org/10.1126/science.aam9080 >> Lesen Sie die Zusammenfassung
Fitzgerald, J. C., Zimprich, A., Carvajal-Berrio, D. A., Schindler, K. M., Maurer, B., Schulte, C., Bus, C., Hauser, A.-K., Kübler, M., Lewin, R., Bobbili, D. R., Schwarz, L. M., Vartholomaiou, E., Brockmann, K., Wüst, R., Madlung, J., Nordheim, A., Riess, O., Martins, L. M., Glaab, E., May, P., Schenke-Layland, K., Picard, D., Sharma, M., Gasser, T., & Krüger, R. (2017). Metformin reverses TRAP1 mutation-associated alterations in mitochondrial function in Parkinson's disease. Brain : A Journal of Neurology, 140(9), 2444-2459.
Glaab, E. (2017) Computational systems biology approaches for Parkinson's disease, Cell and Tissue Research (Special issue Parkinson's disease: Molecules, cells, and circuitries, T. Gasser, H. Braak, K. Del Tredici, Eds.), pp. 1, doi: 10.1007/s00441-017-2734-5
Kolber, P., Stallinger, C., & Krüger, R., (2017). Update zur intensivierten Therapie des fortgeschrittenen idiopathischen Parkinson-Syndroms, Nervenheilkunde, 36(8), pp. 647–654.
Krüger, R., Lingor, P., Doskas, T., Henselmans, J., Danielsen, E. H., de Fabregues, O., Stefani, A., Sensken, S. C., Parra, J. C., Onuk, K., Yegin, A., & Antonini, A. (2017). An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease Patients. Advances in therapy, 34(7), 1741–1752. https://doi.org/10.1007/s12325-017-0571-2
Krüger, R., Klucken, J., Weiss, D., Tönges, L., Kolber, P., Unterecker, S., Lorrain, M., Baas, H., Müller, T., & Riederer, P. (2017). Classification of advanced stages of Parkinson's disease: translation into stratified treatments. Journal of neural transmission (Vienna, Austria : 1996), 124(8), 1015–1027. https://doi.org/10.1007/s00702-017-1707-x >> Lesen Sie die Zusammenfassung
Scholten, M., Klemt, J., Heilbronn, M., Plewnia, C., Bloem, B. R., Bunjes, F., Krüger, R., Gharabaghi, A., & Weiss, D. (2017). Effects of Subthalamic and Nigral Stimulation on Gait Kinematics in Parkinson's disease. Frontiers in neurology, 8, 543.
Seidel, K., Bouzrou, M., Heidemann, N., Krüger, R., Schols, L., den Dunnen, W. F. A., Korf, H.-W., & Rub, U. (2017). Involvement of the cerebellum in Parkinson disease and dementia with Lewy bodies. Annals of neurology, 81(6), pp. 898-903.
Straniero, L., Rimoldi, V., Samarani, M. et al. (2017). The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p. Sci Rep, 7, 12702. https://doi.org/10.1038/s41598-017-12973-5
Trezzi, J., Galozzi, S., Jaeger, C., Barkovits, K., Brockmann, K., Maetzler, W., Berg, D., Marcus, K., Betsou, F., Hiller, K., Mollenhauer, B. (2017) Distinct Metabolomic Signature in Cerebrospinal Fluid in Early Parkinson’s Disease, Movement Disorders,10, pp. 1401, doi: 10.1002/mds.27132
Wang, L., Heckman, M. G., Aasly, J. O., Annesi, G., Bozi, M., Chung, S. J., Clarke, C., Crosiers, D., Eckstein, G., Garraux, G., Hadjigeorgiou, G. M., Hattori, N., Jeon, B., Kim, Y. J., Kubo, M., Lesage, S., Lin, J. J., Lynch, T., Lichtner, P., Mellick, G. D., Mok, V., Morrison, K. E., Quattrone, A., Satake, W., Silburn, P. A., Stefanis, L., Stockton, J. D., Tan, E. K., Toda, T., Brice, A., Van Broeckhoven, C., Uitti, R. J., Wirdefeldt, K., Wszolek, Z., Xiromerisiou, G., Maraganore, D. M., Gasser, T., Krüger, R., Farrer, M. J., Ross, O. A., & Sharma, M. (2017). Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study. Neurobiology of aging, 49, 217.e1-217.e4.
2016
Guebila, M. B., & Thiele, I. (2016). Model-based dietary optimization for late-stage, levodopa-treated, Parkinson’s disease patients. Npj Systems Biology and Applications, 2(1). doi:10.1038/npjsba.2016.13 >> Lesen Sie die Zusammenfassung
Heinzel, S., Roeben, B., Ben-Shlomo, Y., Lerche, S., Alves, G., Barone, P., Behnke, S., Berendse, H. W., Bloem, B. R., Burn, D., Dodel, R., Grosset, D. G., Hu, M., Kasten, M., Krüger, R., Moccia, M., Mollenhauer, B., Oertel, W., Suenkel, U., Walter, U., … Berg, D. (2016). Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned. Frontiers in aging neuroscience, 8, 147. https://doi.org/10.3389/fnagi.2016.00147
Krüger, R., Hilker, R., Winkler, C., Lorrain, M., Hahne, M., Redecker, C., Lingor, P., & Jost, W. H. (2016). Advanced stages of PD: interventional therapies and related patient-centered care. Journal of neural transmission (Vienna, Austria : 1996), 123(1), 31–43. https://doi.org/10.1007/s00702-015-1418-0 >> Lesen Sie die Zusammenfassung
Weiss, D., Herrmann, S., Wang, L., Schulte, C., Brockmann, K., Plewnia, C., Gasser, T., Sharma, M., Gharabaghi, A., Krüger, R. (2016). Alpha-synuclein gene variants may predict neurostimulation outcome. Movement Disorders, 31(4), 601-603. doi:10.1002/mds.26558
Wüst, R., Maurer, B., Hauser, K., Woitalla, D., Sharma, M., & Krüger, R. (2016). Mutation analyses and association studies to assess the role of the presenilin-associated rhomboid-like gene in Parkinson's disease. Neurobiology of aging, 39, . https://doi.org/10.1016/j.neurobiolaging.2015.11.025
2015
Hipp, G. (2015). Das Luxemburger Parkinson-Kohortenprogramm: Neue Strategien für eine umfassende Studie zur Erfassung von Biodaten und klinischen Daten. Basal Ganglia, 5(1). doi:10.1016/j.baga.2015.02.246